NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Overview Fund Activity
Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

14 hedge funds and large institutions have $2.01M invested in Northwest Biotherapeutics, Inc. Common stock in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SL
1
Sentinus LLC
Illinois
$1.37M
2
EFG
2
Ethos Financial Group
Pennsylvania
$13.9K

Top Sellers

1
ECM
1
Estabrook Capital Management
New York
$0
2
MSAM
2
Moloney Securities Asset Management
Missouri
$178K
Name Market Value Shares Shares
Change 		Shares
Change %
SL
1
Sentinus LLC
Illinois
$1.37M 2,190,440 +395,650 +22%
AA
2
Ancora Advisors
Ohio
$329K 526,000 – –
MSAM
3
Moloney Securities Asset Management
Missouri
$178K 284,160 -1,300 -0.5%
OCG
4
Opus Capital Group
Ohio
$38K 60,150 – –
WJWM
5
Williams Jones Wealth Management
New York
$27.5K 44,000 – –
EFG
6
Ethos Financial Group
Pennsylvania
$13.9K 22,200 +22,200 New
MCM
7
MAI Capital Management
Ohio
$12.5K 20,000 – –
LDB
8
Lee, Danner & Bass
Tennessee
$12K 20,000 – –
GWI
9
Grace & White Inc
New York
$9.19K 14,705 – –
AA
10
AlphaMark Advisors
Kentucky
$9K 14,007 – –
AMG
11
Advisors Management Group
Wisconsin
$6K 10,270 – –
BC
12
Bartlett & Co
Ohio
$3K 4,292 – –
BCWM
13
Bartlett & Co Wealth Management
Ohio
$2.68K 4,292 – –
ECM
14
Estabrook Capital Management
New York
– – -7,000 Closed
HFS
15
Hantz Financial Services
Michigan
$0 250 – –